Cargando…

Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E(2)–EP(3) signaling

BACKGROUND: The immunomodulatory and anti-inflammatory functions of human gingiva-derived mesenchymal stromal cells (GMSCs) have been demonstrated in contact hypersensitivity (CHS) models; however, their therapeutic effect during the late phase of CHS has been poor. METHODS: The murine CHS model was...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Pei, Zhao, Yuming, Ge, Lihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969691/
https://www.ncbi.nlm.nih.gov/pubmed/27484807
http://dx.doi.org/10.1186/s13287-016-0361-9
_version_ 1782445824414842880
author Li, Pei
Zhao, Yuming
Ge, Lihong
author_facet Li, Pei
Zhao, Yuming
Ge, Lihong
author_sort Li, Pei
collection PubMed
description BACKGROUND: The immunomodulatory and anti-inflammatory functions of human gingiva-derived mesenchymal stromal cells (GMSCs) have been demonstrated in contact hypersensitivity (CHS) models; however, their therapeutic effect during the late phase of CHS has been poor. METHODS: The murine CHS model was induced by applying oxazolone to the ears of mice. Mesenchymal stromal cells were applied via two methods (intravenous or local injection) at three time points: 1 day before sensitization, 1 day before challenge, or 1 h after challenge. Prostaglandin E(2) (PGE(2)) and sulprostone were administered subcutaneously 1 h after challenge. RESULTS: The application of GMSCs, bone marrow mesenchymal stem cells, and adipose-derived stem cells all effectively suppressed CHS; however, GMSC treatment exhibited the greatest efficacy. Local injection of GMSCs led to a more marked attenuation of CHS compared with intravenous injection, especially during the late phase of CHS, and this manifested as decreased infiltration of inflammatory cells, suppression of the levels of various proinflammatory cytokines, reconstruction of the disrupted Th1/Th2 balance, and upregulation of regulatory T cells in the allergen contact areas. Pretreatment with indomethacin significantly abrogated the GMSC-mediated immunosuppressive effects, while PGE(2) application reversed the effects of indomethacin pretreatment of GMSCs. Moreover, GMSC administration promoted the expression of EP(3), a prostaglandin E receptor, and the application of sulprostone, an agonist of EP(3), significantly attenuated CHS to a similar degree as that of GMSC administration. CONCLUSIONS: GMSCs have reproducible and powerful immunomodulatory functions. Local injection of GMSCs is the superior mode for therapeutic application. PGE(2)–EP(3) signaling plays an important role in the immunomodulatory functions of GMSCs in murine CHS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13287-016-0361-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4969691
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49696912016-08-03 Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E(2)–EP(3) signaling Li, Pei Zhao, Yuming Ge, Lihong Stem Cell Res Ther Research BACKGROUND: The immunomodulatory and anti-inflammatory functions of human gingiva-derived mesenchymal stromal cells (GMSCs) have been demonstrated in contact hypersensitivity (CHS) models; however, their therapeutic effect during the late phase of CHS has been poor. METHODS: The murine CHS model was induced by applying oxazolone to the ears of mice. Mesenchymal stromal cells were applied via two methods (intravenous or local injection) at three time points: 1 day before sensitization, 1 day before challenge, or 1 h after challenge. Prostaglandin E(2) (PGE(2)) and sulprostone were administered subcutaneously 1 h after challenge. RESULTS: The application of GMSCs, bone marrow mesenchymal stem cells, and adipose-derived stem cells all effectively suppressed CHS; however, GMSC treatment exhibited the greatest efficacy. Local injection of GMSCs led to a more marked attenuation of CHS compared with intravenous injection, especially during the late phase of CHS, and this manifested as decreased infiltration of inflammatory cells, suppression of the levels of various proinflammatory cytokines, reconstruction of the disrupted Th1/Th2 balance, and upregulation of regulatory T cells in the allergen contact areas. Pretreatment with indomethacin significantly abrogated the GMSC-mediated immunosuppressive effects, while PGE(2) application reversed the effects of indomethacin pretreatment of GMSCs. Moreover, GMSC administration promoted the expression of EP(3), a prostaglandin E receptor, and the application of sulprostone, an agonist of EP(3), significantly attenuated CHS to a similar degree as that of GMSC administration. CONCLUSIONS: GMSCs have reproducible and powerful immunomodulatory functions. Local injection of GMSCs is the superior mode for therapeutic application. PGE(2)–EP(3) signaling plays an important role in the immunomodulatory functions of GMSCs in murine CHS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13287-016-0361-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-02 /pmc/articles/PMC4969691/ /pubmed/27484807 http://dx.doi.org/10.1186/s13287-016-0361-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Li, Pei
Zhao, Yuming
Ge, Lihong
Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E(2)–EP(3) signaling
title Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E(2)–EP(3) signaling
title_full Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E(2)–EP(3) signaling
title_fullStr Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E(2)–EP(3) signaling
title_full_unstemmed Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E(2)–EP(3) signaling
title_short Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E(2)–EP(3) signaling
title_sort therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin e(2)–ep(3) signaling
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969691/
https://www.ncbi.nlm.nih.gov/pubmed/27484807
http://dx.doi.org/10.1186/s13287-016-0361-9
work_keys_str_mv AT lipei therapeuticeffectsofhumangingivaderivedmesenchymalstromalcellsonmurinecontacthypersensitivityviaprostaglandine2ep3signaling
AT zhaoyuming therapeuticeffectsofhumangingivaderivedmesenchymalstromalcellsonmurinecontacthypersensitivityviaprostaglandine2ep3signaling
AT gelihong therapeuticeffectsofhumangingivaderivedmesenchymalstromalcellsonmurinecontacthypersensitivityviaprostaglandine2ep3signaling